Gne-477

SynDRA canonical compound SYN0609345 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	MTOR \| PIK3CA
Mechanism of action	mtor inhibitor
Indication	renal cell carcinoma (rcc)
Disease area	oncology

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

MTOR
PIK3CA

Cross-references

PubChem CID: 25207689
ChEMBL: CHEMBL1091978

Synonyms

0E8LA9H0RY
RefChem:922402
GNE477
MFCD20527726
UNII-0E8LA9H0RY
C21H28N8O3S2
orb1303889
SCHEMBL1180950
SCHEMBL29367908
GLXC-90033
EX-A2063
GNE 477?
HRB75481
BDBM50315907
s6516
AKOS027420931
CS-3359
NCGC00345851-01
NCGC00345851-02
NCGC00345851-04
AC-31513
AS-16287
DA-33600
HY-11042
GNE-477; GNE477; GNE 477
F85060

Look up Gne-477 in the interactive SynDRA portal →